Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6

Clinical trial NCT03618758 · COMPLETED

Trial details

NCT number: NCT03618758
Sponsor: Seoul National University Bundang Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Stage IV Peritoneal Carcinomatosis Intraperitoneal Paclitaxel mFOLFOX6

Start date: 2018-12-24
Primary completion: 2023-08-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.